Updated:
MARSBIO
MARSBIO is a venture capital based in Los Angeles, founded 2018; the Altss profile covers its classification, headquarters, registration, AUM band, and key...
Overview
Biology that shifts Paradigms — Backing the boldest bioscience entrepreneurs at the earliest stages
General information
Firm type
Venture Capital
Year founded
2018
Location
Region
North America
Country
United States
City
Los Angeles
Corporate office
Los Angeles, CA, United States
Sector focus
Frequently asked questions
Which sectors does MARSBIO invest in?
MARSBIO invests exclusively in biotechnology and adjacent life sciences sectors. The firm's areas of focus include therapeutics platforms, synthetic biology, computational drug discovery, precision diagnostics, and companies engineering biology at the molecular level. It does not invest in general healthcare services or digital health applications divorced from biological platform science.
How does MARSBIO source its deal flow?
The firm's deal sourcing relies on deep relationships within the Southern California research corridor, particularly Caltech, UCLA, and USC. MARSBIO's ongoing engagement with technology transfer offices and academic labs gives it visibility into company formation at the earliest stages. This university-proximate sourcing model is common among specialized biotech seed funds and depends heavily on principal-level scientific networks.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: